STAGE IV UTERINE CORPUS CANCER AJCC V8
Clinical trials for STAGE IV UTERINE CORPUS CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV UTERINE CORPUS CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV UTERINE CORPUS CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Chemotherapy mist shows promise in targeting stomach, ovarian, and colon cancers
Disease control Recruiting nowThis early-stage trial is testing the safety of a new method called PIPAC, which turns chemotherapy into a fine mist and sprays it directly into the abdomen during a minimally invasive surgery. The study includes adults with ovarian, uterine, appendix, stomach, or colorectal canc…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 16, 2026 20:35 UTC
-
New hope for recurrent gynecologic cancers: Drug-Radiation combo enters human testing
Disease control Recruiting nowThis early-stage study tests a drug called talazoparib combined with radiation therapy for people whose gynecologic cancers (ovarian, endometrial, cervical, and others) have returned after prior treatment. The goal is to find the safest dose and see if the combination can shrink …
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Electric field device joins forces with cancer drugs in early trial
Disease control Recruiting nowThis early-phase study tests a wearable device that creates electric fields (tumor treating fields) combined with either cabozantinib or a chemo-immunotherapy pair (nab-paclitaxel and atezolizumab) in people with advanced solid tumors in the abdomen or chest. The goal is to find …
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
New drug combo trial hopes to tame advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called IACS-6274, given alone or with other medicines, in people with advanced solid tumors (like certain melanomas, ovarian, or uterine cancers). The main goal is to find the safest dose and understand side effects. About 54 adults will ta…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 09, 2026 12:10 UTC